Project
This project accelerates the adoption of genomic innovation by supporting delivery of a range of projects which dovetail with the Genomic Medicine Service Alliance (GMSA) mainstreaming strategy. We will improve patient outcomes, in partnership with ICBs, NHS providers, and universities, by enabling access to timely genomic testing and treatment, as well as access to research trials. We also collaborate with innovators to support implementation of existing innovations, as well as identifying new opportunities for novel breakthrough interventions.
Our impact
Embed the outputs of the Genomic Networks of Excellence to improve health outcomes
Drive NHS GMS support for and recruitment to clinical research trials, understanding active clinical trials within the region and nationally
Develop and sustain knowledge of the drivers of genomic innovation and their impact on health care systems.
Health Innovation Wessex and the Central and South Genomic Medicine Service Alliance (CAS GMSA) have partnered to deliver a genomic innovation programme.
NHS England’s Accelerating Genomic Medicine in the NHS strategy sets out a framework for delivering a world leading genomic medicine service. The strategy has four priority areas:
To deliver these genomic priorities, Health Innovation Wessex and CAS GMSA have common aims and objectives of delivering national programmes of work, tackling health inequalities, and delivering regional health priorities.
This genomic programme will focus on nine areas:
The aims of the programme are:
How can we help you?
If you’d like to get in touch please
email enquiries@hiwessex.net